Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday?
From Yahoo Finance: 2025-03-28 04:25:00
On Thursday, the stock market saw major indices in the red as investors sold off positions due to ongoing trade tensions. The Nasdaq fell by 0.53%, Dow Jones by 0.37%, and S&P 500 by 0.33%. Automakers were hit hardest after President Trump announced a 25% tariff on all imported vehicles.
Despite the market decline, 10 companies defied pessimism with fresh developments. Two gold miners stood out as investors sought safer assets. Soleno Therapeutics Inc. (SLNO) surged by 37.61% to $67.39 after FDA approval for its diazoxide choline, Vykat XR, to treat extreme hunger in Prader-Willi syndrome patients.
Prader-Willi syndrome, a rare genetic disorder, causes low muscle tone, developmental delays, and behavioral challenges. Extreme hunger in patients can lead to severe obesity and health complications. FDA’s approval followed a three-month delay due to Soleno’s responses classified as a “major amendment” to its new drug application.
SLNO ranks 2nd among stocks that jumped on Thursday. While SLNO shows potential for investment, some AI stocks may offer higher returns in a shorter time frame. For a promising AI stock trading at less than 5 times its earnings, check out our report on the cheapest AI stock.
Read more at Yahoo Finance: Why Soleno Therapeutics Inc. (SLNO) Surged On Thursday?